GR980300023T1 - Means for treating auto-immune diseases and method of treatment - Google Patents

Means for treating auto-immune diseases and method of treatment

Info

Publication number
GR980300023T1
GR980300023T1 GR980300023T GR980300023T GR980300023T1 GR 980300023 T1 GR980300023 T1 GR 980300023T1 GR 980300023 T GR980300023 T GR 980300023T GR 980300023 T GR980300023 T GR 980300023T GR 980300023 T1 GR980300023 T1 GR 980300023T1
Authority
GR
Greece
Prior art keywords
treatment
immune diseases
glycoprotein
treating auto
autoimmune diseases
Prior art date
Application number
GR980300023T
Other languages
English (en)
Inventor
Ivan Nikolaevich Golovistikov
Leonid Yazonovich Kacharava
Jury Semyonovich Tatarinov
Khallar Abdumuslimov Alikhanov
Original Assignee
Ivan Nikolaevich Golovistikov
Leonid Yazonovich Kacharava
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivan Nikolaevich Golovistikov, Leonid Yazonovich Kacharava filed Critical Ivan Nikolaevich Golovistikov
Publication of GR980300023T1 publication Critical patent/GR980300023T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • External Artificial Organs (AREA)
GR980300023T 1994-03-18 1998-04-30 Means for treating auto-immune diseases and method of treatment GR980300023T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU9494008169A RU2056852C1 (ru) 1994-03-18 1994-03-18 Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний
PCT/RU1995/000047 WO1995025531A1 (fr) 1994-03-18 1995-03-16 Agent therapeutique contre les maladies auto-immunes et mode de traitement

Publications (1)

Publication Number Publication Date
GR980300023T1 true GR980300023T1 (en) 1998-04-30

Family

ID=20153349

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980300023T GR980300023T1 (en) 1994-03-18 1998-04-30 Means for treating auto-immune diseases and method of treatment

Country Status (22)

Country Link
US (1) US6150326A (el)
EP (1) EP0790059B1 (el)
JP (1) JPH09510473A (el)
KR (1) KR100382252B1 (el)
CN (1) CN1146156A (el)
AT (1) ATE260111T1 (el)
AU (1) AU699896B2 (el)
BG (1) BG62759B1 (el)
CA (1) CA2185892A1 (el)
CZ (1) CZ285856B6 (el)
DE (2) DE790059T1 (el)
ES (1) ES2107980T1 (el)
FI (1) FI963671A (el)
GE (1) GEP20012377B (el)
GR (1) GR980300023T1 (el)
HU (1) HUT75720A (el)
NO (1) NO963911L (el)
PL (1) PL179765B1 (el)
RU (1) RU2056852C1 (el)
SK (1) SK281948B6 (el)
UA (1) UA26939C2 (el)
WO (1) WO1995025531A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0030729D0 (en) * 2000-12-16 2001-01-31 Univ Nottingham Substituted-4-Quinolones
CA2501940A1 (en) * 2002-10-09 2004-04-22 Tolerrx, Inc. Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use
RU2303995C1 (ru) * 2006-04-28 2007-08-10 Халлар Абдумуслимович Алиханов Средство, обладающее иммунорегуляторным свойством и его применение для лечения аутоиммунных заболеваний

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862449D1 (en) * 1977-08-22 1984-11-22 Nat Res Dev Macromolecular covalent conjugates, methods for preparing and pharmaceutical compositions containing them
JPS61186322A (ja) * 1985-02-13 1986-08-20 Nippon Univ 免疾調節剤
IT1188646B (it) * 1986-04-09 1988-01-20 Ellem Ind Farmaceutica Tripeptide ad attivita' immunostimolante
US4803072A (en) * 1986-09-10 1989-02-07 Smithkline Beckman Corporation Immunomodulation
FR2609632B1 (fr) * 1987-01-21 1991-03-29 Shelly Marc Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
US5169835A (en) * 1989-01-18 1992-12-08 Oklahoma Medical Research Foundation Pregancy specific proteins applications
FR2650183A1 (fr) * 1989-07-25 1991-02-01 Pasteur Institut Proteines immunostimulantes, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et application de ces produits a des fins therapeutiques et de diagnostic
US5118669A (en) * 1989-09-20 1992-06-02 Hitachi Chemical Co., Ltd. Peptides and intermediates therefor useful as antiallergic agents, vasodilators and immunoregulators
US5559097A (en) * 1990-01-12 1996-09-24 Idaho Research Foundation, Inc. Use of a pregnancy specific protein as an immunosuppressive
RU1836957C (ru) * 1990-03-25 1993-08-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ получени трофобластического бета @ -гликопротеина
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease

Also Published As

Publication number Publication date
SK118796A3 (en) 1997-06-04
DE69532611D1 (de) 2004-04-01
AU2087495A (en) 1995-10-09
CA2185892A1 (en) 1995-09-28
DE790059T1 (de) 1998-03-12
EP0790059B1 (en) 2004-02-25
CZ274796A3 (en) 1997-06-11
UA26939C2 (uk) 1999-12-29
RU2056852C1 (ru) 1996-03-27
PL179765B1 (pl) 2000-10-31
ATE260111T1 (de) 2004-03-15
FI963671A (fi) 1996-11-14
HU9602558D0 (en) 1996-11-28
PL316311A1 (en) 1997-01-06
NO963911L (no) 1996-11-08
BG100921A (en) 1997-12-30
AU699896B2 (en) 1998-12-17
EP0790059A1 (en) 1997-08-20
CN1146156A (zh) 1997-03-26
ES2107980T1 (es) 1997-12-16
JPH09510473A (ja) 1997-10-21
CZ285856B6 (cs) 1999-11-17
SK281948B6 (sk) 2001-09-11
FI963671A0 (fi) 1996-09-17
BG62759B1 (bg) 2000-07-31
EP0790059A4 (en) 2000-11-02
KR970701557A (ko) 1997-04-12
US6150326A (en) 2000-11-21
WO1995025531A1 (fr) 1995-09-28
GEP20012377B (en) 2001-03-25
NO963911D0 (no) 1996-09-18
KR100382252B1 (ko) 2003-07-07
HUT75720A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
SG50585A1 (en) Glycoalkaloids
DE69310677D1 (de) Behandlung von Brennstoffgasen, insbesondere für Brennstoffzellen und Vorrichtung dafür
ATE123810T1 (de) Alpha-subeinheit des lfa-1-leukocyt-adhäsions- rezeptors.
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
ES469328A1 (es) Procedimiento para el enriquecimiento de una nueva glucopre-teina.
BR9808221A (pt) Método de tratamento de tumor.
GB2380939B (en) Treatment or prevention of auto-immune diseases
GR980300023T1 (en) Means for treating auto-immune diseases and method of treatment
ATE107656T1 (de) Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion.
ES2052913T3 (es) Ensayo inmunoquimico en cuanto al factor estimulante de colonias de granulocitos-macrofagos.
JPS5292773A (en) Automatic analyzer
DE3790139D2 (en) Antiparatypical antibodies, their use for detecting and treating auto-immune diseases
ES2002133A6 (es) Dispositivo para la determinacion de un grupo sanguineo
ES8704268A1 (es) Procedimiento para la determinacion cinetica de la actividad del sistema de complemento de sangre de ser humano o de animal mamifero.
BR9807980A (pt) Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva
JPS53148094A (en) Electric discharge machining apparatus
JPS51144293A (en) Continuous analysis system of urine, etc
IE873143L (en) HOMOGENEOUS SHEEP TllTS AS AN INTERMEDIATE FOR THE¹PREPARATION OF HUMAN Tllts, AND THE USE THEREOF
JPS542033A (en) Sort instruction system
UA15554A (uk) Спосіб прогhозуваhhя ефективhості рефлексотерапії за лазориком
UA11489A1 (uk) Спосіб визhачеhhя активhості тімозиhа
ES1010145U (es) Electrodo unico para monitorizacion electrocardiografica.
UA10218A (uk) Спосіб діагностики функції жовтого тіла
UA31956A (uk) Спосіб оцінки ефективності лікування хворих на псоріаз і псоріатичний артрит